MarketInOut Stock Screener Log In | Sign Up

Illumina Inc

XETRA • Healthcare • Diagnostics & Research • Quote as of 10/30/2026
Illumina Inc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeXETRA
Market Capitalization32,133 mln
Float150 mln
Earnings Date10/29/2026

EPS

4.75
Stretched

P / E

44.80
High premium

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.68
Likely reliable

Relative Strength

5 / 100
Severely lagging

Debt / Equity

0.71
Moderate leverage

Business Description

Illumina is a San Diego-based company founded in 1998 that makes tools and equipment used to read and analyze DNA. Its products are sold to hospitals, research institutions, drug companies, and diagnostic labs across the world. The company also partners with organizations like Labcorp and children's health research groups to help advance cancer treatment and the study of rare diseases.

Key Fundamentals

EPS4.75
P/E44.80
ROE32.51
RPS26.57
ROIC17.49
ROA13.63
Interest Cover13.34
EBITDA, mln1,214
EV / EBITDA25.50
EV / EBIT31.74
Revenue, mln3,909
EV / Revenue7.92

Quote Details

Last 212.80
Change -47.55 (-18.26%)
Open 232.20
Volume 784
Turnover 166,835
Average Volume 211.95

Financial Ratios

Pre-Tax Profit Margin23
Leverage Ratio2.34
Current Ratio2.63
Price / Book11.56
Price / Tangible Book24.72
Price / Cash Flow19.23
Price / Free Cash Flow33.10
Debt / Equity0.71
Price / Sales7.99
PEG Ratio3.58

Financial Strength

Altman Z-Score7.38
Piotroski F-Score 8 / 9
Beneish M-Score-2.68
Price to Intrinsic Value4.50
Price to Graham Number8.34

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -11.13% 2 / 100   
1 Month -10.94% 8 / 100   
2 Months 31.72% 98 / 100   
6 Months 105% 100 / 100   
1 Year 154% 99 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog